Clément François
About Clément François
Clément François is a Partner and Head of HTA and Market Access Operations at Putnam PHMR, with extensive experience in health economics and outcomes research. He has held various leadership roles in the healthcare sector and has a strong academic background, including a PhD in Health Economics.
Work at Putnam Associates
Clément François serves as Partner and Head of HTA and Market Access Operations at Putnam PHMR since 2023. In this role, he leads initiatives related to Health Technology Assessment and market access strategies. His extensive experience in health economics and outcomes research supports his leadership in these critical areas.
Current Role at Aix-Marseille University
Since 2017, Clément François has been an Associate Researcher at Aix-Marseille University in Marseille. His research focuses on health economics, contributing to academic advancements in the field. This position complements his professional work in market access and health technology assessment.
Previous Experience at Lundbeck
Clément François held multiple roles at Lundbeck, including Head of Section Health Economics, HEOR Manager, and Divisional Director Global Outcomes Research. His tenure spanned from 1998 to 2017, during which he developed expertise in health economics and outcomes research, significantly impacting the organization's strategic direction.
Education and Expertise
Clément François has a robust academic background, including a PhD in Health Economics from the University of Marseilles, achieved between 2006 and 2010. He also holds a Diploma in Health Economics from the University of York and a Master of Science in Computational and Applied Mathematics from Université Paul Sabatier Toulouse III. His education underpins his expertise in health technology assessment and patient-reported outcomes.
Background in Clinical Research
Clément François has been involved in clinical research, focusing on the development and evaluation of new healthcare interventions. His contributions enhance the understanding of health economics and patient perspectives, aligning with his roles in health technology assessment and market access.